Manage Tickers

Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current
Analyst Rating Guide

News

Back

Fulgent Genetics Raises FY2025 Adj EPS Guidance from $(0.65) to $(0.35) vs $(0.55) Est; Raises FY2025 Sales Guidance from $310.000M to $320.000M vs $310.682M Est

Author: Benzinga Newsdesk | August 01, 2025 06:04am
Fulgent Genetics (NASDAQ:FLGT) raises FY2025 Adj EPS guidance from $(0.65) to $(0.35) vs $(0.55) analyst estimate. Raises FY2025 sales outlook from $310.000 million to $320.000 million vs $310.682 million estimate.

Posted In: FLGT


CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist